Your Source for Venture Capital and Private Equity Financings

Venture Capital News: CancerIQ Raises $14M Series B Funding

2022-05-02
CHICAGO, IL, CancerIQ, announced it closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund and Amgen Ventures.
CancerIQ, a platform powering early cancer detection and prevention across broad patient populations, announced it closed a $14 million Series B financing round co-led by Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures.

McKesson Ventures, OSF Ventures (the investment arm of OSF HealthCare, a current CancerIQ customer), as well as CancerIQ's Series A lead investor, HealthX Ventures, also participated in the Series B round.
(c) by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000+ startups and 5,000+ VC investors